Boris Sepesi, MD, FACS, Director of General Thoracic Surgery, Thoracic Surgical Oncology, Swedish Medical Center
Dr. Boris Sepesi, MD, FACS is a board-certified surgeon, certified in general surgery and thoracic surgery with expertise and experience in the comprehensive treatment of thoracic and upper gastrointestinal oncological diagnoses, specifically lung cancer, esophageal cancer, gastric cancer, chest wall tumors, tracheal and airway tumors, thymomas, thymic carcinomas, mesothelioma and other thoracic oncological diagnoses. His unique training, knowledge and research interests in immunotherapy, targeted therapy, chemotherapy and clinical trials enable him to offer consultation and recommendations for multi-disciplinary perioperative therapy for complex thoracic oncologic diagnoses that require surgical management.
From surgical standpoint, Dr. Sepesi is highly experienced in all surgical techniques: minimally invasive thoracoscopic surgery (VATS), robotic assisted thoracic surgery (RATS) as well as complex open surgical techniques for the surgical treatment of thoracic and upper gastrointestinal malignancies. He personalizes treatment, surgical decisions and patient care based on the symptoms, diagnosis, disease stage, disease extent, body type, and patients’ preferences to achieve the most optimal short-term and long-term outcomes and quality of life.
Along with his extensive expertise in the treatment of thoracic oncological diagnoses, he also manages patients with benign and infectious thoracic and esophageal diseases such as esophageal reflux disease, hiatal hernias, esophageal motility disorders, pleural infections, pneumothorax, or undiagnosed pulmonary nodules and ground glass opacities.
“My goal is to provide the highest level of personalized medical and surgical care by respecting patients’ preferences, autonomy, and dignity, by guiding and coaching patients through the diagnosis and therapeutic journey.”
Financial relationships
-
Attribution:SelfNature of financial relationship:TravelIneligible company:BMSTopic:ESMO 2023Date added:02/21/2024Date updated:02/21/2024Relationship end date:11/30/2023
-
Attribution:SelfNature of financial relationship:OtherIneligible company:Astra ZenecaTopic:speakerDate added:02/21/2024Date updated:02/21/2024Relationship end date:11/30/2023
-
Attribution:SelfNature of financial relationship:OtherIneligible company:PEER ViewTopic:speakerDate added:02/21/2024Date updated:02/21/2024Relationship end date:11/30/2022
-
Attribution:SelfNature of financial relationship:OtherIneligible company:MedscapeTopic:speakerDate added:02/21/2024Date updated:02/21/2024Relationship end date:12/31/2022